NBC Securities’s Trevi Therapeutics TRVI Stock Holding History

NBC Securities’s Portfolio TRVI Stock Details TRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$28.6K	Hold	2,000	–	–	﹤0.01%	1526
2026 Q2	$37.3K	Sell	2,000 -15,000	-88%	-$218K	﹤0.01%	1404
2026 Q1	$203K	Hold	17,000	–	–	0.02%	829
2025 Q4	$213K	Buy	17,000 +15,000	+750%	+$173K	0.02%	817
2025 Q3	$18.3K	Hold	2,000	–	–	﹤0.01%	1783
2025 Q2	$10K	Hold	2,000	–	–	﹤0.01%	1954
2025 Q1	$12K	Buy	2,000 +1,998	+99,900%	+$9.5K	﹤0.01%	1685
2024 Q4	$8	Sell	2 -1,998	-100%	-$6.4K	﹤0.01%	1216
2024 Q3	$6K	Hold	2,000	–	–	﹤0.01%	1858
2024 Q2	$5K	Hold	2,000	–	–	﹤0.01%	1864
2024 Q1	$6K	Hold	2,000	–	–	﹤0.01%	1836
2023 Q4	$2K	Hold	2,000	–	–	﹤0.01%	2037
2023 Q3	$4K	Buy	+2,000	New	+$4.52K	﹤0.01%	1923

Other funds holding TRVI

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

NBC Securities's TRVI Position: Q3 2026 in Review

NBC Securities held its Trevi Therapeutics (TRVI) position steady in Q3 2026 at 2,000 shares worth $28.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1526.

NBC Securities first reported a position in TRVI in Q3 2023 and has held it in 13 quarters since. The position peaked at $213K in Q4 2025. 90 funds tracked by Wall St. Rank hold TRVI as of Q3 2026.

NBC Securities held 2,000 shares of Trevi Therapeutics worth $28.6K as of Q3 2026.
NBC Securities left its Trevi Therapeutics share count unchanged in Q3 2026.
Trevi Therapeutics made up ﹤0.01% of NBC Securities's portfolio in Q3 2026, its #1526 holding.
NBC Securities first reported a position in Trevi Therapeutics in Q3 2023 and has held it in 13 quarters since.
NBC Securities's Trevi Therapeutics position peaked at $213K in Q4 2025.
90 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q3 2026.

Based on NBC Securities's 13F filing for Q3 2026, filed 26 Oct 2026.